Wataru Ichikawa
Department of Clinical Oncology and Medical Oncology
International Medical Center
Saitama Medical University
1397-1 Yamane
Japan
Name/email consistency: high
- Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients. Ichikawa, W., Sasaki, Y. Int. J. Clin. Oncol. (2008)
- Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. Ichikawa, W., Ooyama, A., Toda, E., Sugimoto, Y., Oka, T., Takahashi, T., Shimizu, M., Sasaki, Y., Hirayama, R. Cancer Chemother. Pharmacol. (2006)
- Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1. Ichikawa, W., Takahashi, T., Suto, K., Shirota, Y., Nihei, Z., Shimizu, M., Sasaki, Y., Hirayama, R. Int. J. Cancer (2006)
- Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen. Ichikawa, W., Takahashi, T., Suto, K., Sasaki, Y., Hirayama, R. Clin. Cancer Res. (2006)
- Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients. Ichikawa, W., Sasaki, Y. Ann. Oncol. (2006)
- Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Ichikawa, W., Takahashi, T., Suto, K., Nihei, Z., Shirota, Y., Shimizu, M., Sasaki, Y., Hirayama, R. Int. J. Cancer (2004)
- Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Ichikawa, W., Takahashi, T., Suto, K., Yamashita, T., Nihei, Z., Shirota, Y., Shimizu, M., Sasaki, Y., Hirayama, R. Br. J. Cancer (2004)
- Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Nishi, N., Nihei, Z., Sugihara, K., Hirayama, R. Clin. Cancer Res. (2003)
- Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Takahashi, T., Nihei, Z., Sugihara, K., Sasaki, Y., Hirayama, R. Br. J. Cancer (2003)